<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04634721</url>
  </required_header>
  <id_info>
    <org_study_id>Ultrasound or Laparoscopic TAP</org_study_id>
    <nct_id>NCT04634721</nct_id>
  </id_info>
  <brief_title>Transversus Abdominis Plan Block, Ultrasound or Laparoscopic?</brief_title>
  <official_title>Transversus Abdominis Plan Block Applied in Laparoscopic Cholecystectomies Effective By Which Method: Ultrasound or Laparoscopic?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ankara City Hospital Bilkent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ankara City Hospital Bilkent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Abdominal wall blocks are frequently used as part of multimodal analgesia for pain control&#xD;
      after abdominal surgery. There are studies using the Transversus Abdominis Plane Block for&#xD;
      postoperative pain control in laparoscopic cholecystectomies.&#xD;
&#xD;
      In this study, the investigators aimed to compare the advantages of these two methods by&#xD;
      applying the Transversus Abdominis Plan Block for postoperative pain control after&#xD;
      laparoscopic cholecystectomy with the help of postoperative USG and laparoscopy during&#xD;
      surgery.In this study, the investigators aimed to compare the advantages of these two methods&#xD;
      by applying the Transversus Abdominis Plan Block for postoperative pain control after&#xD;
      laparoscopic cholecystectomy with the help of postoperative USG and LAPAROSCOPY during&#xD;
      surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 60 patients aged 18-65, ASA 1-2-3, who will undergo elective laparoscopic&#xD;
      cholecystectomy in our hospital, will be included in the study. Patients will be randomly&#xD;
      divided into 3 groups with ultrasound (USG) guided (GROUP 1: USG) , Laparoscopic application&#xD;
      (GROUP 2: LAP) and GROUP 3 :No-TAP blok Each group consists of 20 evil people. Written&#xD;
      consent will be obtained by explaining the procedure to be performed before the operation to&#xD;
      the patients. The Transversus Abdominis Plan Block will be applied to the patients by a blind&#xD;
      anesthesiologist according to their group. The block to be made by the anesthesiologist who&#xD;
      will apply the block procedure will be given in a closed envelope.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2020</start_date>
  <completion_date type="Actual">January 15, 2021</completion_date>
  <primary_completion_date type="Actual">December 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean postoperative static and dynamic numeric rating scale (NRS) at 24 hours</measure>
    <time_frame>24 hours</time_frame>
    <description>o compare the mean NRS at 0hr, 1hr, 2 hrs. 6 hrs. 12 hrs. and 24hrs. post-operatively between three groups Numeric rating scale for pain,(0=no pain, 1-3= mild pain, 4-6 moderate pain, 7-10 severe pain.)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post operative nausea or vomiting</measure>
    <time_frame>24 hours</time_frame>
    <description>instances of nausea or vomiting in the post operative period will be recorded</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Total opioid usage</measure>
    <time_frame>24 hours</time_frame>
    <description>amount of opioids used in perioperative period will be recorded</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Bupivacaine</condition>
  <condition>Anesthetics, Local</condition>
  <condition>Anesthetics</condition>
  <condition>Peripheral Nervous System Agents</condition>
  <arm_group>
    <arm_group_label>Laparoscopic TAP block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Laparoscopic assisted TAP block will be done by surgeon intra-operatively</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ultrasaund TAP block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>injecting bupivacaine in transversus abdominis plane to block the somatic nerves</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no TAP block</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>no TAP block would be done</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bupivacaine</intervention_name>
    <description>In one arm the TAP infiltration will contain 10 mL of 0.25 % bupivacaine injected . This will then be repeated on the contralateral side.</description>
    <arm_group_label>Laparoscopic TAP block</arm_group_label>
    <arm_group_label>Ultrasaund TAP block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASA I,II,III&#xD;
&#xD;
          -  Patients 18-65&#xD;
&#xD;
          -  laparoscopic cholecystectomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ASA III higher&#xD;
&#xD;
          -  history of pain relief medication dependence&#xD;
&#xD;
          -  history of substance abuse&#xD;
&#xD;
          -  end stage chronic kidney disease&#xD;
&#xD;
          -  advanced liver disease&#xD;
&#xD;
          -  history of chronic pain -history of taking opioids or neuropathic agents regularly&#xD;
             prior to surgery-&#xD;
&#xD;
          -  BMI of 50 or over&#xD;
&#xD;
          -  skin infections at the site of TAP block injection or port sites.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ankara Şehir Hastanesi</name>
      <address>
        <city>Ankara</city>
        <state>Çankaya</state>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>November 1, 2020</study_first_submitted>
  <study_first_submitted_qc>November 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2020</study_first_posted>
  <last_update_submitted>January 27, 2021</last_update_submitted>
  <last_update_submitted_qc>January 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ankara City Hospital Bilkent</investigator_affiliation>
    <investigator_full_name>Mehmet sahap</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>TAP block</keyword>
  <keyword>laparoscopy</keyword>
  <keyword>laparoscopic cholecystectomy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

